Literature DB >> 24036920

Influence of obesity on localized prostate cancer patients treated with radical prostatectomy.

Yuan-Yuan Qu1, Bo Dai, Yun-Yi Kong, Kun Chang, Ding-Wei Ye, Xu-Dong Yao, Shi-Lin Zhang, Hai-Liang Zhang, Wei-Yi Yang.   

Abstract

This study aimed to investigate the association between different anthropometric measures of obesity and clinicopathological characteristics in Chinese patients with clinically localized prostate cancer (PCa). A total of 734 patients with clinically localized PCa who underwent radical prostatectomy (RP) were included in this study. Clinical and pathological data from each patient were collected. Anthropometric measures of abdominal adiposity were measured from T2-weighted sagittal localisation images from magnetic resonance imaging (MRI) for 413 (56.3%) patients. Patient clinical and pathological characteristics were compared across body mass index (BMI) groups. Univariable and multivariable logistic regression models were used to address the influence of the preoperative total testosterone level and anthropometric measures of obesity on pathological outcomes. In the multivariate analysis, BMI was not significantly associated with any pathological outcomes. However, the percentage of visceral adipose tissue (VAT%) was an independent predictor of a pathological Gleason score ≥8 (P<0.001), extracapsular extension (ECE; P=0.002) and seminal vesicle invasion (SVI; P=0.007). More importantly, we found that the preoperative total testosterone level was significantly correlated with the VAT% (Pearson's correlation coefficient: -0.485, P<0.001) and subcutaneous adipose tissue (SAT; Pearson's correlation coefficient: 0.413, P<0.001). In conclusion, the results of this study suggest that abdominal fat distribution, and particularly VAT%, is associated with a risk of advanced PCa. Moreover, our present study confirms a significant inverse correlation between visceral adiposity and testosterone. Further studies are warranted to elucidate the biological mechanisms underlying the relationship between abdominal adiposity and the aggressiveness of PCa.

Entities:  

Mesh:

Year:  2013        PMID: 24036920      PMCID: PMC3854031          DOI: 10.1038/aja.2013.104

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  29 in total

1.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

Authors:  Christina Wang; Eberhard Nieschlag; Ronald Swerdloff; Hermann M Behre; Wayne J Hellstrom; Louis J Gooren; Jean M Kaufman; Jean-Jacques Legros; Bruno Lunenfeld; Alvaro Morales; John E Morley; Claude Schulman; Ian M Thompson; Wolfgang Weidner; Frederick C W Wu
Journal:  Eur Urol       Date:  2008-08-30       Impact factor: 20.096

Review 2.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

3.  Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.

Authors:  Sabine Rohrmann; Meredith S Shiels; David S Lopez; Nader Rifai; William G Nelson; Norma Kanarek; Eliseo Guallar; Andy Menke; Corinne E Joshu; Manning Feinleib; Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2011-06-16       Impact factor: 2.506

4.  Prevalence of obesity in the United States, 2009-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  NCHS Data Brief       Date:  2012-01

5.  Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.

Authors:  Bo Dai; YuanYuan Qu; YunYi Kong; DingWei Ye; XuDong Yao; ShiLin Zhang; ChaoFu Wang; HaiLiang Zhang; WeiYi Yang
Journal:  BJU Int       Date:  2012-09-14       Impact factor: 5.588

6.  Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.

Authors:  L A Healy; A M Ryan; P Carroll; D Ennis; V Crowley; T Boyle; M J Kennedy; E Connolly; J V Reynolds
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-02-26       Impact factor: 4.126

7.  Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy.

Authors:  Phillip Mucksavage; Christopher Mitchell; Alexander Kutikov; Alan J Wein; Drew Torigian; S Bruce Malkowicz
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

8.  Visceral obesity and colorectal cancer: are we missing the boat with BMI?

Authors:  Aaron S Rickles; James C Iannuzzi; Oleg Mironov; Andrew-Paul Deeb; Abhiram Sharma; Fergal J Fleming; John R T Monson
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

9.  Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma.

Authors:  Yao Zhu; Hong-Kai Wang; Hai-Liang Zhang; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Yi-Jun Shen; Xiao-Hang Liu; Liang-Ping Zhou; Ding-Wei Ye
Journal:  J Urol       Date:  2012-12-14       Impact factor: 7.450

10.  Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.

Authors:  Alexandre Campeggi; Evanguelos Xylinas; Guillaume Ploussard; Idir Ouzaid; Alban Fabre; Yves Allory; Dimitri Vordos; Claude C Abbou; Laurent Salomon; Alexandre de la Taille
Journal:  Urology       Date:  2012-09       Impact factor: 2.649

View more
  8 in total

1.  Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.

Authors:  Emma H Allott; Lauren E Howard; Hai-Jun Song; Katharine N Sourbeer; Bridget F Koontz; Joseph K Salama; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-21       Impact factor: 4.254

2.  Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.

Authors:  Raffaele Baio; Giorgio Napodano; Christian Caruana; Giovanni Molisso; Umberto Di Mauro; Olivier Intilla; Umberto Pane; Costantino D'Angelo; Antonella Bianca Francavilla; Claudio Guarnaccia; Francesca Pentimalli; Roberto Sanseverino
Journal:  Mol Clin Oncol       Date:  2022-06-20

3.  Body Composition and Prostate Cancer Risk: A Systematic Review of Observational Studies.

Authors:  Sarah A Purcell; Camila L P Oliveira; Michelle Mackenzie; Paula Robson; John D Lewis; Carla M Prado
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

4.  Feasibility of a Weight Management Program Tailored for Overweight Men with Localized Prostate Cancer - A Pilot Study.

Authors:  Jill M Hamilton-Reeves; Chelsea N Johnson; Lauren K Hand; Misty D Bechtel; Hilary L Robertson; Carrie Michel; Meredith Metcalf; Prabhakar Chalise; Nicholas J Mahan; Moben Mirza; Eugene K Lee; Debra K Sullivan; Jennifer R Klemp; Christie A Befort; William P Parker; Heather D Gibbs; Wendy Demark-Wahnefried; J Brantley Thrasher
Journal:  Nutr Cancer       Date:  2020-12-09       Impact factor: 2.900

5.  The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.

Authors:  Gui-Ming Zhang; Yao Zhu; Da-Hai Dong; Cheng-Tao Han; Cheng-Yuan Gu; Wei-Jie Gu; Xiao-Jian Qin; Li-Jiang Sun; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

6.  Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.

Authors:  Pei-De Bai; Meng-Bo Hu; Hua Xu; Wen-Hui Zhu; Ji-Meng Hu; Tian Yang; Hao-Wen Jiang; Qiang Ding
Journal:  World J Surg Oncol       Date:  2015-11-05       Impact factor: 2.754

7.  Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.

Authors:  Meng-Bo Hu; Pei-De Bai; Yi-Shuo Wu; Li-Min Zhang; Hua Xu; Rong Na; Hao-Wen Jiang; Qiang Ding
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.

Authors:  Nigel P Murray; Socrates Aedo; Cynthia Fuentealba; Eduardo Reyes; Anibal Salazar; Eghon Guzman; Shenda Orrego
Journal:  Ecancermedicalscience       Date:  2020-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.